Bortezomib for myeloma -- much ado about something

N Engl J Med. 2005 Jun 16;352(24):2546-8. doi: 10.1056/NEJMe058059.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / economics
  • Antineoplastic Agents / therapeutic use*
  • Boronic Acids / adverse effects
  • Boronic Acids / economics
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Dexamethasone / adverse effects
  • Dexamethasone / therapeutic use
  • Humans
  • Multiple Myeloma / drug therapy*
  • Protease Inhibitors / adverse effects
  • Protease Inhibitors / therapeutic use*
  • Pyrazines / adverse effects
  • Pyrazines / economics
  • Pyrazines / therapeutic use*
  • Research Design

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib
  • Dexamethasone